Exousia Bio, Inc.
corporate_fare Company Profile
Exousia Bio, Inc. (OTC:LMMY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for LMMY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-16, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for LMMY spans 10-Q.
Recent high-impact activity:
- Zero Revenue, Net Loss for Exousia Bio in Q3; Strategic Biotech Pivot Underway
- Exousia Bio Faces Liquidity Crisis with Past-Due, Highly Dilutive Convertible Note
- Exousia Bio (LMMY) Reports Going Concern, Pivots to Biotech, Secures Highly Dilutive $250K Convertible Note, and Rescinds 21M Shares
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for LMMY, detected from its recent SEC filings · based on capital-structure filings through 2026-06-16.
Going Concern Warning Issued · Convertible Note Past Due with High Dilution Risk
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →